Budesonide Inhalant
Product Images NDC 0487-9701

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0487-9701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bud Fig 1

A line graph showing mean change from baseline in mean asthma symptom scores over different weeks for placebo and three doses of Budesonide inhalant (0.25 mg, 0.5 mg, 1.0 mg daily). The x-axis represents time in weeks and the y-axis shows change from baseline in symptom scores. P-values for each dose are noted.*

FDA Label Image

Bud Fig 3

A line graph showing the mean change from baseline in nighttime asthma symptoms over a 12-week period for different dosing regimens of Budesonide inhalant compared to placebo. The x-axis represents time intervals from baseline through 12 weeks, while the y-axis shows the mean change in symptoms. Each line corresponds to a dosing group: placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily.*

FDA Label Image

Chemical Structure (Budesonide 01)

Chemical structure of budesonide showing its steroid backbone with oxygen-containing functional groups and side chains, as part of the inhalant medication by Nephron Pharmaceuticals Corporation.*

FDA Label Image

Figure 1 (Budesonide 02)

A line graph showing mean change from baseline in nighttime asthma symptoms over a 12-week period. It compares three groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily dosages of Budesonide inhalant. The y-axis measures mean change from baseline, ranging from -0.6 to 0.1, and the x-axis represents time intervals from baseline through week 0 to 12.*

FDA Label Image

Principal Display Panel (0.25 mg / 2 mL Ampule Carton)

Label for Budesonide Inhalation Suspension 0.25 mg / 2 mL by Nephron Pharmaceuticals Corporation. The label identifies a single unit-dose 2 mL plastic ampule containing a sterile inhalant suspension for respiratory use. Storage and usage instructions are included, emphasizing refrigeration and immediate use after opening.*

FDA Label Image

Principal Display Panel (0.5 mg / 2 mL Ampule Carton)

Packaging label for Budesonide Inhalation Suspension 0.25 mg/2 mL by Nephron Pharmaceuticals Corporation. The label indicates 30 plastic sterile unit-dose ampules per carton, each in a foil pouch. The design includes instructions for use with illustrations, directions to store upright, and a "Rx Only" designation. The product is for inhalation only and made in the USA.*

FDA Label Image

Budesonide 11

Label for Budesonide Inhalation Suspension 0.25 mg/2 mL sterile inhalant ampules by Nephron Pharmaceuticals Corporation. The label includes usage instructions, storage conditions at controlled room temperature (20°-25°C), and a barcode. Pack contains 5 unit-dose 2 mL plastic ampules, Rx only.*

FDA Label Image

Budesonide 12

Packaging label for Budesonide 0.25 mg/2 mL Inhalation Suspension by Nephron Pharmaceuticals Corporation. The label is for 2 mL plastic sterile unit-dose ampules, with a total package size of 30 ampules (6 pouches of 5). Instructions for use and storage details are included on the label.*

FDA Label Image

Budesonide 13

Budesonide Inhalation Suspension 0.5 mg/2 mL unit-dose plastic ampule label. The label states the product is for inhalation only, sterile, and Rx only. It includes preparation and storage instructions, ingredients, and the manufacturer as Nephron Pharmaceuticals Corporation.*

FDA Label Image

Budesonide 14

Packaging label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Nephron Pharmaceuticals Corporation. The label indicates a 30-count package of plastic sterile unit-dose ampules for respiratory inhalation use only. Instructions for use and storage directions are also printed on the label.*

FDA Label Image

Budesonide 15

Label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Nephron Pharmaceuticals Corporation. The label indicates this is a sterile, prescription-only respiratory inhalant in 5 x 2 mL unit-dose plastic ampules. It includes storage instructions, usage directions, and a barcode on the left.*

FDA Label Image

Budesonide 16

The packaging label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Nephron Pharmaceuticals Corporation. The label indicates 2 mL plastic sterile unit-dose ampules, 30 (6 pouches x 5) count. It includes instructions on how to use the inhalation suspension, storage directions, and contact information for customer service. The packaging is primarily white with blue and red accents.*

FDA Label Image

Ifu 04 2020 Update

Illustrated instructions for assembling and using Budesonide inhalation suspension with a nebulizer. Steps show opening single-dose ampules from sealed aluminum foil, shaking the ampule, twisting off the top, placing contents into the nebulizer cup, and using a face mask for inhalation. Includes warnings on storage temperature and disposal of ampules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.